WILMINGTON, Del., March 27, 2013 /PRNewswire/ -- Rigrodsky &
Long, P.A.:
- Do you own shares of Obagi Medical Products, Inc. (NASDAQ
GS: OMPI)?
- Did you purchase any of your shares prior to March 20, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of Obagi
Medical Products, Inc. ("Obagi" or the "Company") (NASDAQ GS: OMPI)
regarding possible breaches of fiduciary duties and other
violations of law related to the Company's entry into an agreement
to be acquired by Valeant Pharmaceuticals International, Inc.
("Valeant") (NYSE: VRX) in a transaction valued at approximately
$344 million.
Click here to learn more:
http://www.rigrodskylong.com/investigations/obagi-medical-products-inc-ompi.
Under the terms of the proposal, public shareholders of Obagi
will receive $19.75 per share in cash
for each share of Obagi they own.
The investigation concerns whether Obagi's board of directors
failed to adequately shop the Company and obtain the best possible
value for Obagi's shareholders before entering into an agreement
with Valeant.
If you own the common stock of Obagi and purchased your shares
before March 20, 2013, if you have
information or would like to learn more about these claims, or if
you wish to discuss these matters or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Seth
Rigrodsky or Brian Long at
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120,
Wilmington, Delaware 19803, by
telephone at (302) 295-5310, or Peter
Allocco at Rigrodsky & Long, P.A., 825 East Gate
Boulevard, Suite 300, Garden City, New
York 11530, by telephone at (888) 969-4242; by e-mail to
info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/obagi-medical-products-inc-ompi.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes
securities class, derivative and direct actions, shareholder rights
litigation and corporate governance litigation, on behalf of
shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a
similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Brian D. Long
Peter Allocco
(888) 969-4242
(302) 295-5310
(516) 683-3516
Fax: (302) 654-7530
info@rigrodskylong.com
http://www.rigrodskylong.com
SOURCE Rigrodsky & Long, P.A.